CO-SALE RIGHTS AGREEMENT
Exhibit 7.5
CO-SALE RIGHTS AGREEMENT
This Co-Sale Rights Agreement (this “Agreement”) is entered into as of October 29, 2004 (the “Agreement Date”), by and among A-Fem Medical Corporation, a Nevada corporation (the “Company”), Xxxxxxx, Xxxxx & Co., a New York limited partnership (“Goldman”), and each of the individuals and entities listed on Schedule A (each, an “Investor”).
BACKGROUND
A. The Company, Goldman and the Investors, have entered into a Stock and Warrant Purchase Agreement (the “Purchase Agreement”) of even date herewith pursuant to which Goldman desires to sell to the Investors and the Investors desire to purchase from Goldman the Shares (as such term is defined in the Purchase Agreement) and Warrants (as such term is defined in the Purchase Agreement).
B. A condition to the obligations under the Purchase Agreement is that the Company, Goldman and the Investors enter into this Agreement in order to provide Goldman with certain rights of co-sale with respect to sales of shares of Common Stock, par value $0.01 per share, of the Company (“Common Stock”).
AGREEMENT
In consideration of the mutual agreements contained in this Agreement, the parties agree as follows:
|
1. |
Co-Sale Rights. |
1.1 Notice of Proposed Transfer. At least five business days before an Investor (a “Selling Holder”) may sell or transfer any shares of Common Stock (the “Offered Shares”) into which shares of Series A Convertible Preferred Stock, par value $0.01 per share, of the Company (“Series A Stock”) have been converted (the “Subject Shares”), such Selling Holder shall deliver to Goldman and the Company a written notice (the “Transfer Notice”) stating: (i) the Selling Holder’s bona fide intention to sell or otherwise transfer Offered Shares; (ii) the name of each proposed purchaser or other transferee (each, a “Proposed Transferee”); (iii) the number of Offered Shares to be transferred to each Proposed Transferee; (iv) the bona fide cash price or the value of the other consideration for which the Selling Holder proposes to transfer the Offered Shares (the “Offered Price”); and (v) the anticipated closing of the sale or transfer of the Subject Shares. Notwithstanding the foregoing, a Selling Holder is not required to deliver a Transfer Notice pursuant to this Section 1.1, if the proposed transfer is permitted pursuant to Section 1.4.
1.2 Right to Participate. If a Selling Holder intends to sell any Offered Shares to a third party, Goldman shall have the right to participate in any sale to a Proposed Transferee upon the same terms and conditions as set forth in the Transfer Notice (the “Co-Sale Right”), subject to the terms and conditions set forth in this Agreement. Goldman may exercise its Co-Sale Right by delivering to the Selling Holder proposing to sell or transfer Offered Shares, within five business days after receipt of the Transfer Notice, written notice of its intention to participate, specifying the number of shares of Common Stock Goldman desires to sell to the Proposed
|
|
1 |
|
Transferee which number shall in no event exceed the product of (x) the quotient of (a) the number of shares of Common Stock Goldman has acquired and holds as a result of, or may acquire, upon exercise of the New Warrant (as defined in the Purchase Agreement) or such other warrant that has been issued to Goldman upon partial exercise or transfer of the New Warrant divided by (b) the sum of the aggregate number of shares of Common Stock then held by the Investors (assuming full conversion and exercise of all convertible or exercisable securities) plus the number of shares of Common Stock then held by Goldman (assuming full exercise of the New Warrant or such other warrant that has been issued to Goldman upon partial transfer or exercise of the New Warrant) multiplied by (y) the number of shares of Common Stock to be acquired by the Proposed Transferee (the “Transferred Shares”), rounded down to the nearest whole number. At the closing of the purchase and sale of the Transferred Shares, as determined by the Selling Holder and the Proposed Transferee, Goldman shall deliver to the Selling Holder or a designated agent one or more certificates representing the number of shares of Common Stock Goldman elects to sell hereunder, duly endorsed for transfer to the Proposed Transferee.
1.3 Continuing Rights. The exercise or non-exercise of Xxxxxxx’x Co-Sale Rights with respect to a particular sale of Transferred Shares by a Selling Holder shall not adversely affect Xxxxxxx’x Co-Sale Rights with respect to subsequent sales of Subject Shares.
1.4 Permitted Transfers by Selling Holders. Goldman shall have no Co-Sale Rights with respect to: (i) any pledge of Subject Shares made by an Investor in a bona fide loan transaction with a commercial bank that creates a mere security interest; (ii) the donative transfer to an Investor’s relatives by blood, marriage or adoption (each a member of the Selling Holder’s “Immediate Family”); (iii) the transfer to a trust established by the Selling Holder for the benefit of one or more members of such Selling Holder’s Immediate Family; (iv) sales or other transfers by an Investor which when aggregated together do not exceed 1,000,000 Subject Shares; or (v) the transfer of any Subject Shares in the event of a Complete Change of Control. For purposes of this Agreement the term “Complete Change of Control” means a merger of the Company with or into any entity that is not an affiliate of the Company or the acquisition of all of the outstanding capital stock by any person or entity that is not an affiliate of the Company. In addition, nothing in this Agreement shall be construed to waive any obligations of Goldman under the New Warrant, including without limitation the conditions and procedures for exercise thereunder.
2. Termination. This Agreement shall terminate: (i) when Goldman owns less than 200,000 shares of Common Stock (assuming full exercise of the New Warrant or such other warrant that has been issued to Goldman upon partial transfer or exercise of the New Warrant); (ii) the filing by or against the Company of any petition under the U.S. Bankruptcy Code, or the appointment of any receiver or trustee over the Company’s assets; (iii) immediately prior to the consummation of a public offering pursuant to a registration statement filed with the Securities and Exchange Commission of any shares of Common Stock of the Company; or (iv) immediately prior to the occurrence of a Complete Change of Control.
3. Legend and Transfer Restrictions. Each Investor agrees that the Company may instruct its transfer agent to impose transfer restrictions on the Subject Shares, to enforce the provisions of this Agreement. The certificates evidencing Subject Shares held by the Investors shall bear, in addition to any other legend required under federal or applicable state securities
|
|
2 |
|
laws, the legend set forth below. The legend shall be removed upon termination of this Agreement.
THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN CO-SALE RIGHTS AS SET FORTH IN A CO-SALE RIGHTS AGREEMENT ENTERED INTO BY THE HOLDER OF THESE SHARES, THE COMPANY AND XXXXXXX SACHS & CO. A COPY OF SUCH AGREEMENT MAY BE EXAMINED AT THE PRINCIPAL OFFICE OF THE COMPANY.
|
4. |
Miscellaneous. |
4.1 Successors and Assigns. Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. The rights of Goldman hereunder are only assignable by Goldman to affiliates of Goldman. The assignees of rights or obligations under this Agreement must agree in writing to be bound by the terms and conditions of this Agreement.
4.2 Amendments or Waivers. This Agreement or any provision hereof may be amended, waived, discharged or terminated only by a statement in writing signed by the party against which enforcement of the amendment, waiver, discharge or termination is sought.
4.3 Notices, Etc. All notices and other communications required or permitted hereunder shall be in writing and shall be deemed given and served for all purposes when personally delivered, three business days after a writing is deposited in the United States mail, first class postage prepaid, or one business day after a writing is deposited with a nationally recognized overnight courier service for overnight delivery, delivery fees prepaid to the address set forth below, or to such other address as such party shall have specified in a written notice given to the other parties hereto:
(a) if to an Investor, to such Investor’s address on file with the Company,
(b) if to the Company:
A-Fem Medical Corporation
X.X. Xxx 0000
Xxxxxxxxxxx, XX 00000
Attention: Xxxxxxx Xxxxxxx
(c) if to Goldman:
Xxxxxxx, Xxxxx & Co.
00 Xxxxx Xxxxxx
Xxx Xxxx, XX 00000
Attention: Xxxxx Xxxx, Managing Director
with a copy to:
|
|
3 |
|
Obsidian Finance Group, LLC
XX Xxx 0000
00 Xxxxx Xxxx
Xxxxxxxx, XX 00000
Attention: Xxxxx X. Xxxxxxx
4.4 Severability. In case any provision of this Agreement shall be found by a court of law to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.
4.5 Governing Law. This Agreement shall be construed in accordance with, and governed in all respects by, the laws of the State of Oregon, without giving effect to principles of conflicts of laws.
4.6 Counterparts and Facsimile Delivery. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Any signature page delivered by facsimile transmission shall be binding to the same extent as an original signature page, with regard to any agreement subject to the terms hereof or any amendment thereto. Any party who delivers such a signature page agrees to later deliver an original counterpart to any party who requests it.
4.7 Titles and Subtitles. The titles of the sections and subsections of this Agreement are for convenience or reference only and are not to be considered in construing this Agreement.
4.8 Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof and they supersede, merge and render void every other prior written or oral understanding or agreement among or between the parties hereto.
4.9 Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under this Agreement are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under this Agreement. Nothing contained in this Agreement, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group with respect to such obligations or the transactions to be consummated pursuant to this Agreement. Each Investor shall be entitled to independently protect and enforce its rights, including the rights arising out of this Agreement, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose. Each Investor represents that it has been represented by its own separate legal counsel in its review and negotiation of this Agreement. For reasons of administrative convenience only, the Investors acknowledge and agree that they and their respective counsel have chosen to communicate with Company and Company’s counsel through Xxxxxxx XxXxxxxxx LLP (“Xxxxxxx”), but neither Xxxxxxx nor Company’s counsel represent any of the Investors with respect to this Agreement and the transactions contemplated hereby, except that Xxxxxxx represents Sherbrooke Partners, LLC and Xxxx Capital, LLC.
|
|
4 |
|
The parties have executed this Co-Sale Rights Agreement as of the Agreement Date.
|
A-FEM MEDICAL CORPORATION
By: /s/ Xxxxxxx X. Xxxxxxx
Name: Xxxxxxx X. Xxxxxxx
Its: Secretary
|
XXXXXXX, SACHS & CO.
By: /s/ Illegible
Name:
Its:
|
|
SHERBROOKE PARTNERS, LLC
By: /s/ Xxxxxxx Xxxx Xxxxxxx Xxxx, Managing Member
|
XXXX CAPITAL, LLC
By: /s/ Xxxx Xxxxxx Xxxx Xxxxxx, Managing Member |
|
/s/ Xxxxxxx Xxxx XXXXXXX XXXX CUST FOR XXXXX XXXX |
/s/ Xxxxxxx Xxxx XXXXXXX XXXX CUST FOR XXXXXX XXXX |
|
/s/ Xxxx Xxxxxx XXXX XXXXXX CUST FOR XXXXXXXXX XXXXXX |
/s/ Xxxx Xxxxxx XXXX XXXXXX CUST FOR XXXXXXXXX XXXXXX |
|
/s/ Xxxxxxx Xxxxxxx Xxxxxxx Xxxxxxx |
/s/ Xxxx Xxxxxxx Xxxx Xxxxxxx |
|
/s/ Xxxxxxxx Xxxx Xxxxxxxx Xxxx |
/s/ Xxxx Xxxxxx Xxxx Xxxxxx |
|
/s/ Xxxx Xxxxxx Xxxx Xxxxxx FBO Xxxxx Xxxxxxx |
/s/ Xxxx Xxxxxx Xxxx Xxxxxx FBO Xxx Xxxxxxx |
|
/s/ Xxxx Xxxxxx Xxxx Xxxxxx FBO Xxxxx Xxxxx
|
/s/ Xxxx Xxxxxx Xxxx Xxxxxx FBO Xxxxx Xxxxx |
|
Xxxxx and Xxxxxxx Xxxx JTWROS
/s/ Xxxxx Xxxx Xxxxx Xxxx
/s/ Xxxxxxx Xxxx Xxxxxxx Xxxx |
Xxxxxx X. & Xxxxxx X. Xxxxxxxx JTWROS
/s/ Xxxxxx X. Xxxxxxxx Xxxxxx X. Xxxxxxxx
/s/ Xxxxxx X. Xxxxxxxx Xxxxxx X. Xxxxxxxx |
|
/s/ Xxxxx Xxxxxxx Xxxxx Xxxxxxx |
/s/ Xxxxx Xxxx Xxxxx Xxxx |
|
/s/ Xxxxxxx Xxxxxx Xxxxxxx Xxxxxx |
/s/ Xxxxx Xxxxxx Xxxxx Xxxxxx |
|
CGA RESOURCES, LLC
By: /s/ Xxxx Xxxxxxx Xxxxxxx Xxxx Xxxxxxx Xxxxxxx, Sole Member |
/s/ Xxxxxxx Xxxx Xxxxxxx Xxxx |
SCHEDULE A
SCHEDULE OF INVESTORS
|
Investor |
Shares |
Warrants |
|
Xxxx Capital, LLC |
1,750,000 |
642,006 |
|
Sherbrooke Partners, LLC |
1,750,000 |
462,006 |
|
CGA Resources, LLC |
700,000 |
100,000 |
|
Xxxxxxx Xxxxxxx |
375,000 |
0 |
|
Xxxxxxx Xxxx cust for Xxxxxx Xxxx |
300,000 |
0 |
|
Xxxxxxx Xxxx cust for Xxxxx Xxxx |
300,000 |
0 |
|
Xxxxx and Xxxxxxx Xxxx JTWROS |
275,000 |
0 |
|
Xxxxxxxx Xxxx |
250,000 |
0 |
|
Xxxx Xxxxxx cust for Xxxxxxxxx Xxxxxx |
250,000 |
0 |
|
Xxxx Xxxxxx cust for Xxxxxxxxx Xxxxxx |
250,000 |
0 |
|
Xxxxxxx Xxxx |
200,000 |
0 |
|
Xxxxxx X. & Xxxxxx X. Xxxxxxxx JTWROS |
200,000 |
0 |
|
Xxxxx Xxxxxx |
200,000 |
0 |
|
Xxxxx Xxxxxxx |
200,000 |
0 |
|
Xxxx Xxxxxx |
192,135 |
0 |
|
Xxxx Xxxxxxx |
100,000 |
0 |
|
Xxxxx Xxxx |
100,000 |
0 |
|
Xxxx Xxxxxx FBO Xxxxx Xxxxxxx |
25,000 |
0 |
|
Xxxx Xxxxxx FBO Xxx Xxxxxxx |
25,000 |
0 |
|
Xxxx Xxxxxx XXX Xxxxx Xxxxx |
25,000 |
0 |
|
Xxxx Xxxxxx FBO Xxxxx Xxxxx |
25,000 |
0 |
|
|
|
|
|
|
7,492,135 |
1,204,012 |
